Published 08:21 IST, February 17th 2021

Johnson & Johnson files for COVID-19 vaccine approval from EU

Janssen vaccine candidate can prevent ‘moderate’ to ‘severe’ COVID-19 infection, 28 days after the dose was administered, Johnson & Johnson said in a filing.

Reported by: Zaini Majeed

Follow:

null | Image: self

08:21 IST, February 17th 2021